Intravacc offers state-of-the-art analytical methods for identity, content, purity, structure, formulation, stability, and preclinical ...
The implications extend well beyond cost savings. By enabling formulation feasibility work at the pre-IND or Phase I stage, pharmaceutical companies can: ...
Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation ...
In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...
Built for biologics formulation and process development workflows, Rapid pH Plus combines enhanced throughput with modernized ...
Process characterization and viral clearance validation are pivotal studies in biopharmaceutical manufacturing, particularly for monoclonal antibodies (mAbs) produced in mammalian systems, which carry ...
The primary components of LNP–RNA are ionizable lipids, cholesterol, PEGylated lipids, and phospholipids, which together form the nanoparticle, along with the active pharmaceutical ingredient, RNA.
VANCOUVER, BC / ACCESS Newswire / June 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results